Intermittent Fasting Following Acute Ischemic Stroke
Primary Purpose
Ischemic Stroke, Intermittent Fasting
Status
Unknown status
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Intermittent Fasting
Sponsored by
About this trial
This is an interventional treatment trial for Ischemic Stroke
Eligibility Criteria
Inclusion Criteria:
- Patients who was diagnosed first ischemic stroke within preceeding 1 year through brain MRI/CT
Exclusion Criteria:
- Musculo-skeletal disease with limbs malformation or joint contracture
- Weigh more than 135 kg or taller than 195 cm
- Diabetes mellitus
- unstable patient in neurology
- Refusal of participation
Sites / Locations
- Ulsan University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intermittent Fasting
Ad libitium
Arm Description
Over rehabilitation treatment during and admission (at least 1 week), intermittent fasting (IF) for more than 12 hours (water can be allowed). For subgroup assignment, participants can choose IF1 (eat early in the evening and late in the morning) or Post-IF2 (eat the remaining two meals without breakfast), depending on own their faver.
Participants will be allowed to have hospital meals and all the desired intake without time limit.
Outcomes
Primary Outcome Measures
Change of Surface electromyography
root mean square and root peak square of compound motor action potential
Secondary Outcome Measures
Change of Korean-modified Barthel index
Korean version-Modified Barthel Index (minimum of 0 and maximum scores of 100); higher values and a better outcome.
Full Information
NCT ID
NCT03789409
First Posted
December 20, 2018
Last Updated
December 15, 2019
Sponsor
Ulsan University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03789409
Brief Title
Intermittent Fasting Following Acute Ischemic Stroke
Official Title
Intermittent Fasting Following Acute Ischemic Stroke: Prospective, Randomized, Parallel Group, Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2019
Overall Recruitment Status
Unknown status
Study Start Date
March 4, 2019 (Actual)
Primary Completion Date
January 31, 2021 (Anticipated)
Study Completion Date
January 31, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ulsan University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Despite numerous kinds of evidence on functional health and CNS protection of intermittent fasting after injuries were found in many brain-, and spinal cord-damaged animal models, there has yet to be any clinical study of intermittent fasting after acute ischemic cerebral infarction. The aim of this study is to evaluate the neurological, functional and clinical efficacy of intermittent fasting in patients after acute ischemic stroke.
Detailed Description
In order to verify the validity and clinical efficacy of intermittent fasting for neurological and functional effects of ischemic cerebral infarction, the first ischemic stroke (diagnosed within 1 year through brain MRI / CT) patients will be randomly assigned to intermittent fasting group or control group. In both groups, physical therapy, occupational therapy and speech therapy will be provided during 3 hours in total a day. The intermittent fasting group should maintain intermittent fasting for no less than 12 hours or more every day during the rehabilitation period (at least 1 week), and the control group is able to eat all of the hospital meals and all the participants want without any time limit. The efficacy of intermittent fasting is to be verified by performing the electro-physiological tests and functional evaluations before participation, 1st week, 2nd weeks after participation, before discharge, 3 months, and 6 months after the stroke onset.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ischemic Stroke, Intermittent Fasting
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
68 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intermittent Fasting
Arm Type
Experimental
Arm Description
Over rehabilitation treatment during and admission (at least 1 week), intermittent fasting (IF) for more than 12 hours (water can be allowed). For subgroup assignment, participants can choose IF1 (eat early in the evening and late in the morning) or Post-IF2 (eat the remaining two meals without breakfast), depending on own their faver.
Arm Title
Ad libitium
Arm Type
No Intervention
Arm Description
Participants will be allowed to have hospital meals and all the desired intake without time limit.
Intervention Type
Dietary Supplement
Intervention Name(s)
Intermittent Fasting
Intervention Description
The aforementioned intermittent fasting in arm/group descriptions.
Primary Outcome Measure Information:
Title
Change of Surface electromyography
Description
root mean square and root peak square of compound motor action potential
Time Frame
1 day before the initiation of intervention, and 6 months after the stroke onset
Secondary Outcome Measure Information:
Title
Change of Korean-modified Barthel index
Description
Korean version-Modified Barthel Index (minimum of 0 and maximum scores of 100); higher values and a better outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Other Pre-specified Outcome Measures:
Title
Change of Mini mental status exam
Description
Mini mental status exam(minimum of 0 and maximum scores of 30); higher values and a better outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Beck depression inventory
Description
Beck depression inventory(minimum of 0 and maximum scores of 63); higher values and a worse outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Wecsler aphasia battery
Description
Wecsler aphasia battery(minimum of 0 and maximum scores of 100); higher values and a better outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Berg balance scale
Description
Berg balance scale(minimum of 0 and maximum scores of 56); higher values and a better outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Functional Ambulation Category
Description
Functional Ambulation Category(minimum of 0 and maximum scores of 5); higher values and a better outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Motricity Index
Description
Motricity Index(minimum of 0 and maximum scores of 99); higher values and a better outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of 10m walking test
Description
10m walking test
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Grasping force (kg)
Description
Grasping force (kg)
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of 9-hole pegboard
Description
9-hole pegboard
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Jebsen Taylor test
Description
Jebsen-Taylor Hand Function Test
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Nottingham sensory scale
Description
Nottingham sensory scale(minimum of 0 and maximum scores of 20); higher values and a better outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Arm motor Fugl-Mayer scale
Description
Arm motor Fugl-Mayer scale; wrist & hand/proximal arm(minimum of 0 and maximum scores of 24 and of 34, respectively ); higher values and a better outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Stroke impact scale
Description
Hand motor, Stroke Impact Scale (minimum of 12 and maximum scores of 60); higher values and a better outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Ashworth scale
Description
Ashworth scale; elbow, wrist, knee & ankle(minimum of 0 and maximum scores of 4); higher values and a worse outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Knee joint kinesthesia
Description
The smallest iso-kinetic angle from which the participants could detect any passive flexion or extension movement of their own knee, using Biodex; (minimum of 0 and maximum scores of 360 degree); higher values and a worse outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Behavioral inatention test
Description
Behavioral inatention test(minimum of 0 and maximum scores of 146); higher values and a better outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of Apraxia screen of Tulia
Description
Apraxia screen of (minimum of 0 and maximum scores of 12); higher values and a better outcome.
Time Frame
1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset
Title
Change of motor evoked potential
Description
Amplitude (uV) of motor evoked potential was recorded on abductor pollicis brevis and extentor digitorum brevis following trans-cranial magnetic stimulation for cortico-spinal excitability.
Time Frame
1 day before the initiation of intervention, and 6 months after the stroke onset
Title
Change of Weight
Description
Weight (Kg)
Time Frame
1 day before the start of intervention and 1 weeks and 2 weeks after the start of intervention
Title
Change of Temperature
Description
temperature (Celsius)
Time Frame
1 day before the start of intervention and 1 weeks and 2 weeks after the start of intervention
Title
Change of Serum glucose level
Description
Serum glucose level (mg/ml)
Time Frame
1 day before the start of intervention and 1 weeks and 2 weeks after the start of intervention
Title
Change of Hypoglycemia-related severity
Description
Assessment of hypoglycemic symptoms using Likert scale (minimum of 0 and maximum scores of 10); higher values and a worse outcome.
Time Frame
every day following the start of intervention until 2 weeks of intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who was diagnosed first ischemic stroke within preceeding 1 year through brain MRI/CT
Exclusion Criteria:
Musculo-skeletal disease with limbs malformation or joint contracture
Weigh more than 135 kg or taller than 195 cm
Diabetes mellitus
unstable patient in neurology
Refusal of participation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chang Ho Hwang
Phone
+82-52-250-7210
Email
chhwang1220ciba@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chang Ho Hwang, M.D., Ph.D.
Organizational Affiliation
Ulsan University Hospital
Official's Role
Study Director
Facility Information:
Facility Name
Ulsan University Hospital
City
Ulsan
ZIP/Postal Code
682-714
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chang Ho Hwang, M.D., Ph.D.
Phone
+82-52-250-7210
Email
chhwang1220ciba@gmail.com
First Name & Middle Initial & Last Name & Degree
Chang Ho Hwang, M.D., Ph.D.
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Intermittent Fasting Following Acute Ischemic Stroke
We'll reach out to this number within 24 hrs